Compare DFI Retail Nusantara Tbk. (HERO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DFI Retail Nusantara Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? DFI Retail Nusantara Tbk. trades at Rp330 (market cap 1.36T, 298K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: DFI Retail Nusantara Tbk. is far larger — about 8.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and DFI Retail Nusantara Tbk. is more actively traded (298K versus 71K). Which is the better fit depends on your goals.
| HERO | OBAT | |
|---|---|---|
Market Cap | 1.36T | 167.37B |
Volume | 298K | 71K |
Lot | 2.98K | 710 |
Turnover | 98.02M | 17.51M |
Average Price | 328.94 | 246.63 |
Value | 98.02M | 17.51M |
Indicative Equilibrium Price | 330 | 246 |
Indicative Equilibrium Volume | 40 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DFI Retail Nusantara Tbk.
The company began its commercial operations in August 1972. Hero is Indonesia’s largest supermarket chain with a network of 66 supermarkets, consisting of 44 stores in Greater Jakarta and 22 stores in major regional cities. Supermarket operations account for about 90% of sales complemented by an array of retail formats including convenience stores, mini markets, and pharmacies. The company’s mission is to be the leading modern food retailer in Indonesia in terms of sales and profits, targeting the middle to upper income consumer segments where buying power is greatest. As the economy begins to gather strength, HERO has relatively aggressive expansion plans drawing upon its established brand, a reputation for fresh quality foods, friendly experienced staff, best service, a leading position in category and space management and efficient centralized distribution infrastructure. In 1998 the acquisition of a 32% effective interest in Hero by Dairy Farm International contributed significant international experience and expertise to the local knowledge and insight of Hero’s management as well as recognition of the potential of Indonesia as one of the most attractive growth markets in South East Asia over the medium long term.
Read more on HERO →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
